Form 8-K - Current report:
SEC Accession No. 0001104659-25-004747
Filing Date
2025-01-21
Accepted
2025-01-21 08:50:35
Documents
50
Period of Report
2025-01-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253758d1_8k.htm   iXBRL 8-K 34961
2 EXHIBIT 99.1 tm253758d1_ex99-1.htm EX-99.1 54580
6 GRAPHIC tm253758d1_ex99-1img001.jpg GRAPHIC 61743
7 GRAPHIC tm253758d1_ex99-1img002.jpg GRAPHIC 345214
8 GRAPHIC tm253758d1_ex99-1img003.jpg GRAPHIC 210623
9 GRAPHIC tm253758d1_ex99-1img004.jpg GRAPHIC 154449
10 GRAPHIC tm253758d1_ex99-1img005.jpg GRAPHIC 174067
11 GRAPHIC tm253758d1_ex99-1img006.jpg GRAPHIC 170930
12 GRAPHIC tm253758d1_ex99-1img007.jpg GRAPHIC 162442
13 GRAPHIC tm253758d1_ex99-1img008.jpg GRAPHIC 96335
14 GRAPHIC tm253758d1_ex99-1img009.jpg GRAPHIC 56401
15 GRAPHIC tm253758d1_ex99-1img010.jpg GRAPHIC 355802
16 GRAPHIC tm253758d1_ex99-1img011.jpg GRAPHIC 173096
17 GRAPHIC tm253758d1_ex99-1img012.jpg GRAPHIC 205163
18 GRAPHIC tm253758d1_ex99-1img013.jpg GRAPHIC 173901
19 GRAPHIC tm253758d1_ex99-1img014.jpg GRAPHIC 204986
20 GRAPHIC tm253758d1_ex99-1img015.jpg GRAPHIC 161436
21 GRAPHIC tm253758d1_ex99-1img016.jpg GRAPHIC 229882
22 GRAPHIC tm253758d1_ex99-1img017.jpg GRAPHIC 182345
23 GRAPHIC tm253758d1_ex99-1img018.jpg GRAPHIC 138719
24 GRAPHIC tm253758d1_ex99-1img019.jpg GRAPHIC 191069
25 GRAPHIC tm253758d1_ex99-1img020.jpg GRAPHIC 206380
26 GRAPHIC tm253758d1_ex99-1img021.jpg GRAPHIC 165471
27 GRAPHIC tm253758d1_ex99-1img022.jpg GRAPHIC 165934
28 GRAPHIC tm253758d1_ex99-1img023.jpg GRAPHIC 165472
29 GRAPHIC tm253758d1_ex99-1img024.jpg GRAPHIC 164637
30 GRAPHIC tm253758d1_ex99-1img025.jpg GRAPHIC 112994
31 GRAPHIC tm253758d1_ex99-1img026.jpg GRAPHIC 57285
32 GRAPHIC tm253758d1_ex99-1img027.jpg GRAPHIC 170742
33 GRAPHIC tm253758d1_ex99-1img028.jpg GRAPHIC 231411
34 GRAPHIC tm253758d1_ex99-1img029.jpg GRAPHIC 200826
35 GRAPHIC tm253758d1_ex99-1img030.jpg GRAPHIC 435542
36 GRAPHIC tm253758d1_ex99-1img031.jpg GRAPHIC 169089
37 GRAPHIC tm253758d1_ex99-1img032.jpg GRAPHIC 184203
38 GRAPHIC tm253758d1_ex99-1img033.jpg GRAPHIC 204696
39 GRAPHIC tm253758d1_ex99-1img034.jpg GRAPHIC 118737
40 GRAPHIC tm253758d1_ex99-1img035.jpg GRAPHIC 116802
41 GRAPHIC tm253758d1_ex99-1img036.jpg GRAPHIC 146883
  Complete submission text file 0001104659-25-004747.txt   9196138

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20250116.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20250116_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20250116_pre.xml EX-101.PRE 22375
52 EXTRACTED XBRL INSTANCE DOCUMENT tm253758d1_8k_htm.xml XML 3683
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 25540629
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)